The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication

被引:15
作者
Batisse, Julien [1 ]
Guerrero, Santiago [1 ]
Bernacchi, Serena [1 ]
Sleiman, Dona [2 ,3 ]
Gabus, Caroline [4 ]
Darlix, Jean-Luc [4 ]
Marquet, Roland [1 ]
Tisne, Carine [2 ,3 ]
Paillart, Jean-Christophe [1 ]
机构
[1] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France
[2] Univ Paris 05, CNRS, UMR 8015, Lab Cristallog, F-75006 Paris, France
[3] Univ Paris 05, CNRS, UMR 8015, RMN Biol, F-75006 Paris, France
[4] Univ Lyon 1, INSERM U758, ENS L, Dept Virol Humaine, F-69365 Lyon, France
关键词
HIV-1; Vif; Protein oligomerization; RNA chaperone; HUMAN-IMMUNODEFICIENCY-VIRUS; E3 UBIQUITIN LIGASE; TYPE-1 NUCLEOCAPSID PROTEIN; VIRAL INFECTIVITY FACTOR; REVERSE TRANSCRIPTION PRODUCTS; APOBEC3 RESTRICTION FACTORS; PRIMER BINDING-SITE; STRONG-STOP DNA; MESSENGER-RNA; ANTIVIRAL ACTIVITY;
D O I
10.1016/j.virusres.2012.06.018
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The viral infectivity factor (Vif) is essential for the productive infection and dissemination of HIV-1 in non-permissive cells that involve most natural HIV-1 target cells. Vif counteracts the packaging of two cellular cytidine deaminases named APOBEC3G (A3G) and A3F by diverse mechanisms including the recruitment of an E3 ubiquitin ligase complex and the proteasomal degradation of A3G/A3F, the inhibition of A3G mRNA translation or by a direct competition mechanism. In addition, Vif appears to be an active partner of the late steps of viral replication by participating in virus assembly and Gag processing, thus regulating the final stage of virion formation notably genomic RNA dimerization and by inhibiting the initiation of reverse transcription. Vif is a small pleiotropic protein with multiple domains, and recent studies highlighted the importance of Vif conformation and flexibility in counteracting A3G and in binding RNA. In this review, we will focus on the oligomerization and RNA chaperone properties of Vif and show that the intrinsic disordered nature of some Vif domains could play an important role in virus assembly and replication. Experimental evidence demonstrating the RNA chaperone activity of Vif will be presented. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:361 / 376
页数:16
相关论文
共 188 条
[1]   Host cell-dependent replication of HIV-1 mutants with deletions in gp41 cytoplasmic tail region is independent of the function of Vif [J].
Akari, H ;
Yoshida, A ;
Fukumori, T ;
Adachi, A .
MICROBES AND INFECTION, 2000, 2 (09) :1019-1023
[2]   High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site [J].
Akari, H ;
Fujita, M ;
Kao, S ;
Khan, MA ;
Shehu-Xhilaga, M ;
Adachi, A ;
Strebel, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12355-12362
[3]   Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics [J].
Albin, John S. ;
Harris, Reuben S. .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2010, 12
[4]   APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells [J].
Anderson, Jenny L. ;
Hope, Thomas J. .
VIROLOGY, 2008, 375 (01) :1-12
[5]   The HIV-1 Tat protein stimulates reverse transcription in vitro [J].
Apolloni, Ann ;
Meredith, Luke W. ;
Suhrbier, Andreas ;
Kiernan, Rosemary ;
Harrich, David .
CURRENT HIV RESEARCH, 2007, 5 (05) :474-483
[6]   Paradigm development: Comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (vif) [J].
Balaji, Seetharaaman ;
Kalpana, Rangaswamy ;
Shapshak, Paul .
BIOINFORMATION, 2006, 1 (08) :290-309
[7]   Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein [J].
Bampi, C ;
Bibillo, A ;
Wendeler, M ;
Divita, G ;
Gorelick, RJ ;
Le Grice, SFJ ;
Darlix, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) :11736-11743
[8]   Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region [J].
Baraz, L ;
Hutoran, M ;
Blumenzweig, I ;
Katzenellenbogen, M ;
Friedler, A ;
Gilon, C ;
Steinitz, M ;
Kotler, M .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :2225-2230
[9]   Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors:: co-encapsidation and interference with viral protease-mediated Gag processing [J].
Bardy, M ;
Gay, B ;
Pébernard, S ;
Chazal, N ;
Courcoul, M ;
Vigne, R ;
Decroly, E ;
Boulanger, P .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :2719-2733
[10]   Advances in the structural understanding of Vif proteins [J].
Barraud, Pierre ;
Paillart, Jean-Christophe ;
Marquet, Roland ;
Tisne, Carine .
CURRENT HIV RESEARCH, 2008, 6 (02) :91-99